A 4-Arm Efficacy and Safety Study of RT001 for the Treatment of Moderate to Severe Lateral Canthal Lines in Adults

NCT01124552 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

180

Enrollment

INDUSTRY

Sponsor class

Conditions

Lateral Canthal Lines
Crow's Feet
Facial Wrinkles

Interventions

DRUG: RT001 Botulinum toxin type A (Dose A)
DRUG: RT001 Botulinum Toxin Type A (Dose B)
OTHER: Vehicle
DRUG: Placebo

Sponsor

Revance Therapeutics, Inc.